Advertisement

The complex interface between economy and healthcare: An introductory overview for clinicians

Published:August 28, 2016DOI:https://doi.org/10.1016/j.ejim.2016.07.030

      Highlights

      • Efficiency means maximizing the benefit from a pre-determined budget.
      • Cost-effectiveness and cost-utility analysis are the principal methods.
      • QALYs allow to compare treatments in different health sectors.
      • Patients' needs and preferences should be integrated within the healthcare budget.
      • Implementation of economic evaluation in health care should increase social equity.

      Abstract

      In a period of generalized economic crisis, it seems particularly appropriate to try to manage a continuing growing sector such as healthcare in the best possible way. The crucial aim of optimization of available healthcare resources is obtaining the maximum possible benefit with the minimum expenditure. This has important social implications, whether individual citizens or tax-funded national health services eventually have to pay the bill. The keyword here is efficiency, which means either, maximizing the benefit from a fixed sum of money, or minimizing the resources required for a defined benefit. In order to achieve these objectives, economic evaluation is a helpful tool. Five different types of economic evaluation exist in the health-care field: cost-minimization, cost–benefit, cost-consequences, cost-effectiveness and cost-utility analysis. The objective of this narrative review is to provide an overview of the principal methods used for economic evaluation in healthcare. Economic evaluation represents a starting point for the allocation of resources, the decision of the valuable investments and the division of budgets across different health programs. Moreover, economic evaluation allows the comparison of different procedures in terms of quality of life and life expectancy, bearing in mind that cost-effectiveness is only one of multiple facets in the decision making-process. Economic evaluation is important to critically evaluate clinical interventions and ensure that we are implementing the most cost-effective management protocols. Clinicians are called to fulfill the complex task of optimizing the use of resources, and, at the same time, improving the quality of healthcare assistance.

      Abbreviations:

      EE (economic evaluation), OECD (Organization for Economic Co-operation and Development), CEA (cost-effectiveness analysis), CER (cost-effectiveness ratio), ICER (incremental cost-effectiveness ratio), WTP (willingness to pay), NICE (National Institute for Health and Clinical Excellence), CUA (cost-utility analysis), QALY (quality adjusted life year), HUI (Health Utilities Index), SF-6D (Short-form 6D), EQ-5D (Euro Quality of life 5 Dimensions)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kernick D.P.
        Introduction to health economics for the medical practitioner.
        Postgrad Med J. 2003; 79: 147-150
      1. OECD Health Statistics 2015 — country notes.
        ([last visit 05/01/2016])
      2. OECD Health Statistics 2015.
        ([last visit 23/12/2015])
        • Rudmik L.
        • Drummond M.
        Health economic evaluation: important principles and methodology.
        Laryngoscope. 2013; 123: 1341-1347
        • Zilberberg M.D.
        • Shorr A.F.
        Understanding cost-effectiveness.
        Clin Microbiol Infect. 2010; 16: 1707-1712
        • Vernazza C.
        • Heasman P.
        • Gaunt F.
        • Pennington M.
        How to measure the cost-effectiveness of periodontal treatments.
        Periodontol 2000. 2012; 60: 138-146
        • Hamilton D.
        • Hulme C.
        • Flood L.
        • Powell S.
        Cost-utility analysis and otolaryngology.
        J Laryngol Otol. 2014; 128: 112-118
        • McFarland A.
        Economic evaluation of interventions in health care.
        Nurs Stand. 2014; 29: 49-58
        • Krummenauer F.
        • Landwehr I.
        Incremental cost effectiveness evaluation in clinical research.
        Eur J Med Res. 2005; 10: 18-22
        • Noyes K.
        • Holloway R.G.
        Evidence from cost-effectiveness research.
        NeuroRx. 2004; 1: 348-355
        • McCabe C.
        • Claxton K.
        • Culyer A.J.
        The NICE cost effectiveness threshold: what it is and what that means.
        Pharmacoeconomics. 2008; 26: 733-744
        • Brazier J.E.
        • Dixon S.
        • Ratcliffe J.
        The role of patient preferences in cost-effectiveness analysis: a conflict of values?.
        Pharmacoeconomics. 2009; 27: 705-712
        • Maynard A.
        • Bloor K.
        Regulation of the pharmaceutical industry: promoting health or protecting wealth?.
        J R Soc Med. 2015; 108: 220-222
        • Douglas H.R.
        • Normand C.
        Economic evaluation: what does a nurse manager need to know?.
        J Nurs Manag. 2005; 13: 419-427
        • Brown G.C.
        • Brown M.M.
        • Sharma S.
        Value-based medicine: evidence-based medicine and beyond.
        Ocul Immunol Inflamm. 2003; 11: 157-170
        • Brown M.M.
        Health care economic analyses.
        Curr Opin Ophthalmol. 2003; 14: 117-121
        • Busbee B.G.
        • Brown G.C.
        • Brown M.M.
        Cost-effectiveness of ocular interventions.
        Curr Opin Ophthalmol. 2003; 14: 132-138
        • Brown M.M.
        • Brown G.C.
        • Sharma S.
        • Landy J.
        Health care economic analyses and value-based medicine.
        Surv Ophthalmol. 2003; 48: 204-223
        • Brown G.C.
        • Brown M.M.
        • Sharma S.
        Health care economic analyses.
        Retina. 2004; 24: 139-146
        • Kernick D.
        An introduction to the basic principles of health economics for those involved in the development and delivery of headache care.
        Cephalalgia. 2005; 25: 709-714
        • Mitton C.
        • Jarrell J.F.
        Economic evaluation in obstetrics and gynaecology: principles and practice.
        J Obstet Gynaecol Can. 2003; 25: 219-223
        • Virgili G.
        • Koleva D.
        • Garattini L.
        • Banzi R.
        • Gensini G.F.
        Utilities and QALYs in health economic evaluations: glossary and introduction.
        Intern Emerg Med. 2010; 5: 349-352
        • Higgins A.M.
        • Harris A.H.
        Health economic methods: cost-minization, cost-effectiveness, cost-utility, and cost–benefit evaluations.
        Crit Care Clin. 2012; 28: 11-24
        • Moayyedi P.
        • Mason J.
        Cost-utility and cost–benefit analyses: how did we get there and where are we going?.
        Eur J Gastroenterol Hepatol. 2004; 16: 527-534
        • Lin G.A.
        • Redberg R.F.
        Addressing overuse of medical services one decision at a time.
        JAMA Intern Med. 2015; 175: 1092-1093
        • Vercellini P.
        • Giudice L.C.
        • Evers J.L.
        • Abrao M.S.
        Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal.
        Hum Reprod. 2015; 30: 1996-2004
        • Lee T.H.
        Putting the value framework to work.
        N Engl J Med. 2010; 363: 2481-2483
        • Colla C.H.
        Swimming against the current — what might work to reduce low-value care?.
        N Engl J Med. 2014; 371: 1280-1283
        • Schwartz F.H.
        The challenge of deadopting low-value care.
        Ann Intern Med. 2014; 161: 842-843
        • Kim R.D.
        • Kapur V.K.
        • Redline-Bruch J.
        • Rueschman M.
        • Auckley D.H.
        • Benca R.M.
        • et al.
        An economic evaluation of home versus laboratory-based diagnosis of obstructive sleep apnea.
        Sleep. 2015; 38: 1027-1037
        • Tompa E.
        • Dolinschi R.
        • Alamgir H.
        • Sarnocinska-Hart A.
        • Guzman J.
        A cost–benefit analysis of peer coaching for overhead lift use in the long-term care sector in Canada.
        Occup Environ Med. 2016; 73: 308-314
        • Al Shakarchi J.
        • Inston N.
        • Jones R.G.
        • Maclaine G.
        • Hollinworth D.
        Cost analysis of the Hemodialysis Reliable Outflow (HeRO) Graft compared to the tunneled dialysis catheter.
        J Vasc Surg. 2016; 63: 1026-1033
        • Bernard-Arnoux F.
        • Lamure M.
        • Ducray F.
        • Aulagner G.
        • Honnorat J.
        • Armoiry X.
        The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.
        Neuro Oncol. 2016; 0: 1-8
        • Murphy A.
        • McCarthy F.P.
        • McElroy B.
        • Khashan A.S.
        • Spillane N.
        • Marchocki Z.
        • et al.
        Day care versus inpatient management of nausea and vomiting of pregnancy: cost utility analysis of a randomised controlled trial.
        Eur J Obstet Gynecol Reprod Biol. 2016; 197: 78-82